Protalix Biotherapeutics Inc
PLX1.780USD
+0.050+2.89%
Market hours （ET）Quotes delayed by 15 min
143.01MMarket Cap
23.75P/E TTM
Protalix Biotherapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
53.40M
-18.47%
EPS(YoY)
0.04
-67.17%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its total revenue reached 53.40M, with a year-on-year change of -18.47%.
What is the Earnings Per Share (EPS) of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.040, with a year-on-year change of -67.17%.
What is the net income of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its net income was 2.93M, with a year-on-year change of -64.73%.
What is the net margin of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its net profit margin was 5.49%, with a year-on-year change of -56.74%.
What is the gross margin of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its gross margin was 54.46%, with a year-on-year change of -16.10%.
What is the debt-to-asset ratio of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of -100.00%.
What is the Return on Equity (ROE) of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 7.64%, with a year-on-year change of -89.47%.
What is the Return on Assets (ROA) of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 3.71%, with a year-on-year change of -68.67%.
What is the operating profit of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its operating profit was 3.92M, with a year-on-year change of -62.55%.
What are the current assets of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its current assets were 60.08M, with a year-on-year change of -14.09%.
What are the total assets of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its total assets of Protalix Biotherapeutics Inc were 73.42M, with a year-on-year change of -13.05%.
What are the total liabilities of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its total liabilities of Protalix Biotherapeutics Inc were 30.21M, with a year-on-year change of -40.62%.
What is the total equity of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its total equity of Protalix Biotherapeutics Inc was 43.21M, with a year-on-year change of 28.72%.
What is the net operating income of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its net operating income of Protalix Biotherapeutics Inc was 2.93M, with a year-on-year change of -64.73%.
What is the net investment of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its net investment of Protalix Biotherapeutics Inc was 4.22M, with a year-on-year change of 125.26%.
What is the net financing of Protalix Biotherapeutics Inc?
According to Protalix Biotherapeutics Inc's FY2024 earnings report, its net financing of Protalix Biotherapeutics Inc was -16.79M, with a year-on-year change of -168.09%.
